Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Population‐Based Cohort

Objective To identify the incidence, risk factors, and outcomes of rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) and to assess time trends in the incidence and mortality in RA‐ILD. Methods We included adult residents of Olmsted County, Minnesota with incident RA between 1999 and...

Full description

Saved in:
Bibliographic Details
Published inArthritis care & research (2010) Vol. 74; no. 12; pp. 2042 - 2049
Main Authors Samhouri, Bilal F., Vassallo, Robert, Achenbach, Sara J., Kronzer, Vanessa L., Davis, John M., Myasoedova, Elena, Crowson, Cynthia S.
Format Journal Article
LanguageEnglish
Published Boston, USA Wiley Periodicals, Inc 01.12.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To identify the incidence, risk factors, and outcomes of rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) and to assess time trends in the incidence and mortality in RA‐ILD. Methods We included adult residents of Olmsted County, Minnesota with incident RA between 1999 and 2014. Subjects were followed until death, emigration, or April 30, 2019. ILD was defined as the presence of a radiologist‐defined pattern consistent with ILD on chest computed tomography (CT). When chest CT was absent, the combination of chest radiograph abnormalities compatible with ILD and restrictive pattern on pulmonary function testing was considered consistent with ILD. Potential risk factors included age, sex, smoking, obesity, seropositivity, extraarticular manifestations (EAMs), and medications. For survival analysis, we matched RA‐ILD patients to RA–non‐ILD comparators. The frequency and mortality from clinician‐diagnosed RA‐ILD from 1999 to 2014 was compared against a cohort from 1955 to 1994. Results During the 1999–2014 time period, 645 individuals (70% women) had incident RA, were a median age of 55.3 years, and 53% never smoked. Twenty‐two patients had ILD before RA, and 51 (67% women) developed ILD during follow‐up. The 20‐year cumulative incidence of RA‐ILD was 15.3%. Ever‐smoking (hazard ratio [HR] 1.92), age at RA onset (HR 1.89 per 10‐year increase), and severe EAMs (HR 2.29) were associated with incident RA‐ILD. The RA‐ILD cases had higher mortality than their matched RA comparators (HR 2.42). Incidence of RA‐ILD was non‐significantly lower from 1999 to 2014 than from 1955 to1994, but mortality was improved. Conclusions RA‐ILD occurs in nearly 1 in 6 patients with RA within 20 years and is associated with shorter survival. Lack of significant change in RA‐ILD incidence over 6 decades deserves further investigation.
Bibliography:The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Supported by the NIH (grant R01‐AR‐46849 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, award R01‐AG‐034676 from the National Institute of Aging [the Rochester Epidemiology Project], and grant UL1‐TR‐002377 from the National Center for Advancing Translational Sciences).
https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Facr.24856&file=acr24856‐sup‐0001‐Disclosureform.pdf
No potential conflicts of interest relevant to this article were reported.
.
Author disclosures are available at
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2151-464X
2151-4658
2151-4658
DOI:10.1002/acr.24856